Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Medifactia is a Swedish digital health company that develops evidence-based medical education and communication tools for healthcare professionals and patients. The company's flagship product, Inhaler Academy, is a digital platform designed to improve inhaler technique and treatment adherence for patients with asthma and COPD. By providing interactive, validated training modules, Medifactia helps bridge the gap between clinical prescriptions and correct medication delivery. The company collaborates with pharmaceutical partners and academic institutions to integrate its educational solutions into standard clinical workflows. Medifactia's mission is to optimize the management of respiratory diseases through scalable digital technology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Medifactia.